Well I am back in today, after a long absence.
A great product which will sell very well imho. Much needed for patients and big savings for health authorities.
I'm pleased they are doing proper trials now, the new management seem sound and talk sense and now the funding issue is gone.
So my first nibble a 4c - but will look to increase my holdings further down the track.
